Cigna Reshuffles Leadership: Evanko Named President & COO
Snack-Sized Version:
Cigna has appointed Brian Evanko as its new president and COO to drive growth and enhance customer focus. Evanko, previously CEO and CFO of Cigna Healthcare, will assume responsibility for all business lines under CEO David Cordani starting March 31. Ann Dennison has also been named EVP and CFO, overseeing all financial operations. She joined Cigna in early 2024 after serving as Nasdaq’s CFO. Meanwhile, Eric Palmer will leave the company at the end of April after a 25-year career. Cigna reaffirmed its 2025 financial outlook despite a drop in 2024 profits due to higher medical costs. The company posted $3.4 billion in profits for the year, down from $5.2 billion in 2023.
Read the Full Meal:
Cigna has announced key leadership changes, appointing Brian Evanko as president and chief operating officer. Evanko, who previously served as CEO and CFO of Cigna Healthcare, will now oversee all business lines under the leadership of Chairman and CEO David Cordani. The restructuring aims to strengthen Cigna’s focus on customers and accelerate its long-term growth strategy. Evanko has been with the company since 1998, holding multiple leadership positions both in the U.S. and internationally. His expanded role is expected to enhance operational efficiency and reinforce Cigna’s position in the healthcare market.
Additionally, Cigna has appointed Ann Dennison as executive vice president and chief financial officer. Dennison, who joined Cigna in early 2024 as deputy CFO, brings extensive financial expertise from her tenure as Nasdaq’s CFO. She will be responsible for overseeing all enterprise financial operations and functions, reporting directly to Cordani. Her experience in corporate finance, investor relations, and ESG reporting positions her as a key figure in Cigna’s financial strategy moving forward.
At the same time, longtime Cigna executive Eric Palmer is set to depart at the end of April. Palmer currently leads Evernorth Health Services, which expanded significantly under his leadership. His departure marks the end of a 25-year tenure at the company. Cigna has expressed confidence in Evernorth’s sustained growth beyond his exit.
Financially, Cigna reaffirmed its 2025 earnings outlook, despite challenges in 2024. The company expects full-year consolidated adjusted income from operations of at least $29.50 per share. However, profits declined in 2024, with full-year earnings dropping to $3.4 billion from $5.2 billion in 2023. The decline was attributed to higher medical costs, which impacted the company’s financial performance. Nonetheless, Cigna remains optimistic about its long-term strategy and leadership reshuffle.